Details

NBD AI Bulletin - Sinoma Science & Technology Co Ltd (the Company, SZ 002080, close price: 41.98 yuan) announced on September 16 that the Company's cumulative intraday closing price deviation reached +20% over three consecutive trading days (September 14, September 15 and September 16 of 2021). It has been verified that there is no need to correct or supplement the previously disclosed information and the Company and its controlling shareholder and actual controller do not have any significant matters that should have been disclosed or that are in the planning stage.

The semi-annual report of 2021 shows that the main business of Sinoma Science & Technology Co Ltd is special fiber composites, accounting for 100.0% of revenue.

Sinoma Science & Technology Co Ltd's chairman is Xue Zhongmin, male, 55 years old, Ph.D, professor-level senior engineer. Sinoma Science & Technology Co Ltd's president is Huang Zaiman, male, 52 years old, master's degree, professor-level senior engineer.

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk. 

Details

NBD AI Bulletin -- Asymchem Laboratories (Tianjin) Co., Ltd (SZ 002821, close price: 418.5 yuan) on September 16 announced that the Company's deputy general manager Chen Chaoyong on the day offloaded about 10,700 shares, representing 0.0044% of the Company's total equity.

The semi-annual report of 2021 shows that Asymchem Laboratories (Tianjin) Co Ltd's main business is the pharmaceutical industry, accounting for 100.0% of revenue.

Asymchem Laboratories (Tianjin) Co Ltd's chairman and general manager is Hao Hong, male, 65 years old, American national, Ph.D. in pharmaceutical chemistry, Chinese Academy of Medical Sciences, postdoctoral in pharmaceutical chemistry, Georgia University, USA.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.

Details

NBD AI Bulletin - Hangzhou Tigermed Consulting Co Ltd (the Company, SZ 300347, close price: 161.26 yuan) announced on September 16 that shareholder Ms. Zhuan Yin's stock reduction plan has passed the halfway mark but she hasn't offloaded any share.

The 2020 annual report shows that the main business of Hangzhou Tigermed Consulting is the service industry, accounting for 99.5% of revenue.

Hangzhou Tigermed Consulting Co., Ltd. is chaired by Ye Xiaoping, male, 58, Chinese national, no permanent residence abroad, Ph.D. from University of Oxford, the UK. The Company's general manager is Cao Xiaochun, 52, Chinese national, no permanent residence abroad, bachelor's degree, practicing pharmacist, deputy senior engineer.

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk. 

Details

NBD AI Bulletin -- Ming Yang Smart Energy Group Limited (SH 601615, close price: 24.64 yuan) on September 16 announced that the Company received a notice from Joint Hero, saying that the latter cumulatively offloaded about 21.7 million shares in the Company, representing 1.11% of the Company's total equity.

The 2020 annual report shows that Ming Yang Smart Energy Group Limited's main business is product sales revenue, power generation and flashlight income, other, accounting for 93.28%, 4.41%, 1.67% of revenue, respectively.

Ming Yang Smart Energy Group Limited's chairman is Zhang Chuanwei, male, 59 years old, Chinese national, master's degree.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.

Details

NBD AI Bulletin - Shanghai Fosun Pharmaceutical (Group) Co Ltd (the Company, SH 600196, close price: 57.51 yuan) on September 16 said that the Company and and Fosun International Limited will provide joint liability guarantee for majority-owned subsidiary FMH's loan credit of no more than 70 million euros with a duration of no more than 1 year at Australia and New Zealand Banking Group Limited. Of that, the Company will provide guarantee for FMH's loan amount of no more than 38.5 million euros.

The semi-annual report of 2021 shows that Shanghai Fosun Pharmaceutical (Group) Co Ltd's main business is pharmaceutical manufacturing and R&D, medical device services, medical services, accounting for 72.25%, 16.74%, 10.88% of revenue, respectively. 

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.